Nardeen Billan’s Insights

40 total results. Page 1 of 4.

Alerts
50 Shades of Legally Gray: FDA’s Juicy Peptide Cliffhanger
Investigations Blog
Done Global Founder and Clinical President Sentenced for $90 Million Adderall Distribution and Health Care Fraud Scheme
Consumer Products Watch
‘Made in Texas’? Hold Your Horses! FTC Fires Off More ‘Made in the USA’ Warning Letters
Investigations Blog
Telemedicine Company Owner Receives 10-Year Prison Sentence for Medicare Fraud Scheme
Alerts
No Courthouse, No Problem: Rule 45(c)’s Remote Testimony Fix
AI Law Blog
House GAAIA Discussion Draft Proposes Federal AI Governance Framework
AI Law Blog
Trump’s New AI EO: Voluntary Frameworks, Cyber Crackdowns, and What It Means for Developers and Tech Companies 
Consumer Products Watch
What Do the Latest EO and the FTC Have in Common? Hint: Check for a ‘Made in the USA’ Label
News
Brain Computer Interfaces Boot Up Multipronged Legal Issues
Longevity Lens
The Shot Heard ‘Round the Pharmacy’: FDA Takes Aim at GLP-1 Compounders
Alerts
Who Gets the Last Word? SCOTUS Takes on Sentencing Guidelines Deference in Beaird v. United States
Longevity Lens
The Amino-zing World of Peptide Regulation